MBX Biosciences, Inc.
MBX Biosciences is a clinical-stage biopharmaceutical company developing peptide-based treatments for obesity and endocrine disorders, with 90 employees and $238M in total funding. Its lead candidate is a potential once-weekly therapy.
The growth story
MBX Biosciences, Inc. grew from 13 to 90 employees between 2021 and 2026, raising $238M along the way, most recently a Series C in August 2024.
About
MBX Biosciences develops Precision Endocrine Peptides (PEPs) designed to improve on existing therapies for obesity and rare endocrine disorders. Its proprietary peptide delivery platform aims to enhance efficacy, tolerability, and convenience compared to current treatments.
The company has raised $238M, including a Series C round in August 2024, and employs 90 people. It is advancing a pipeline of novel candidates with clinically validated targets and established endpoints for regulatory approval.
Founders and leadership
MBX Biosciences is led by a team with backgrounds in biopharmaceuticals and peptide therapeutics. The largest function is Research, with 8 employees identified in this area. The company operates from dual headquarters in Carmel, Indiana and Burlington, Massachusetts.
The MBX Biosciences, Inc. org chart
Mark Soued (Chief Commercial Officer) leads 46 mapped leaders with 6 direct reports. Click +N to expand a team; names link to the person’s public profile.
- Sr. Vice President Discovery & Non-Clinical DevelopmentExecutive
Departments, and which ones grew
Headcount by function: Research 28 (+40% YoY), Business Development 8 (+33% YoY), Human Resources 6 (+20% YoY), Operations 5 (+150% YoY), Finance 5 (+150% YoY), Administrative 5 (+67% YoY).
Talent flow
MBX Biosciences draws talent primarily from major pharmaceutical companies, with Eli Lilly and Company being the top source. Alumni have moved to roles at Roche, ES Clinical Research, and startups like Kailera Therapeutics. The median tenure is 1 year.
Most common previous employers of MBX Biosciences, Inc. staff: Eli Lilly and Company (6), bluebird bio (4), Sanofi (4), Novartis (4), Albireo Pharma (3), Inotiv (3). Former MBX Biosciences, Inc. employees most often moved to Roche (2), ES Clinical Research (1), Kailera Therapeutics (1), Athysis (1), Twilight Venture Partners (1), ProSciento (1).
Alumni worth knowing
Web traffic
Traffic mix: 18% direct, 54% search, 18% social, 3% paid.
What this company is made of
Most common skills at MBX Biosciences, Inc.: Microsoft Office (29), Biotechnology (29), Leadership (26), Pharmaceutics (25), Microsoft Excel (25), Drug Development (22), Clinical Trials (21), Project Management (21).
Where the team actually sits
MBX Biosciences, Inc. people are concentrated in Indiana, United States (10), Massachusetts, United States (10), United States (10), Greater Boston (7).
Search footprint
MBX Biosciences, Inc. attracts about 523 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 67 ranking keywords and lost 24 in the last period.
What employees say
- Compensation
- 4.30 / 5
- Career opportunities
- 3.50 / 5
- Senior management
- 3.50 / 5
- Work-life balance
- 2.80 / 5
Frequently asked
MBX Biosciences, Inc. has 90 employees as of September 2026.
MBX Biosciences, Inc. has raised $238M in total, most recently a Series C round in August 2024.
Mark Soued (Chief Commercial Officer) sits at the top of MBX Biosciences, Inc.'s reporting structure, with 6 direct reports.
The most common previous employers of current MBX Biosciences, Inc. staff are Eli Lilly and Company (6 people), bluebird bio (4 people), Sanofi (4 people).
Former MBX Biosciences, Inc. employees most often move to Roche (2), ES Clinical Research (1), Kailera Therapeutics (1).
MBX Biosciences, Inc. attracts about 523 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among MBX Biosciences, Inc. staff are Microsoft Office, Biotechnology, Leadership, Pharmaceutics, Microsoft Excel.
MBX Biosciences, Inc. staff are concentrated in Indiana, United States (10), Massachusetts, United States (10), United States (10).
MBX Biosciences, Inc. has about 28 people in Research, up 40% over the past year, as of September 2026.
MBX Biosciences, Inc. has about 8 people in Business Development, up 33% over the past year, as of September 2026.
Computed from 70 current and 31 former MBX Biosciences, Inc. profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.